Literature DB >> 22147616

Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake.

Ji Chen1, Russell D Folks, Liudmila Verdes, Daya N Manatunga, Arnold F Jacobson, Ernest V Garcia.   

Abstract

BACKGROUND: The purpose of this study was to evaluate global quantitation of cardiac uptake on I-123 mIBG SPECT.
METHODS: The study included a pilot group of 67 subjects and a validation group of 1,051 subjects. SPECT images were reconstructed by filtered backprojection, ordered subsets expectation maximization, and deconvolution of septal penetration, respectively. SPECT heart-to-mediastinum ratio (H/M) was calculated by comparing the mean counts between heart and mediastinum volumes of interest drawn on transaxial images. Receiver operating characteristic (ROC) analysis was used to assess the capability of each SPECT method to differentiate the heart disease subjects from controls in comparison with that of the planar H/M.
RESULTS: In the validation group, the areas under the ROC curves were not significantly different between the SPECT and planar H/M. Order subsets expectation maximization had significantly larger area under the ROC curve than the other two SPECT methods.
CONCLUSION: H/M obtained from I-123 mIBG SPECT was equivalent to the planar H/M for differentiating between subjects with normal and abnormal mIBG uptake. Global quantification of cardiac I-123 mIBG SPECT may represent a viable alternative to the planar H/M.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147616     DOI: 10.1007/s12350-011-9438-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

1.  Improved quantification in 123I cardiac SPECT imaging with deconvolution of septal penetration.

Authors:  Ji Chen; Ernest V Garcia; James R Galt; Russell D Folks; Ignasi Carrio
Journal:  Nucl Med Commun       Date:  2006-07       Impact factor: 1.690

Review 2.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

3.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

Authors:  P Merlet; C Benvenuti; D Moyse; F Pouillart; J L Dubois-Randé; A M Duval; D Loisance; A Castaigne; A Syrota
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

4.  Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.

Authors:  T Nakata; K Miyamoto; A Doi; H Sasao; T Wakabayashi; H Kobayashi; K Tsuchihashi; K Shimamoto
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

5.  Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.

Authors:  A Cohen-Solal; Y Esanu; D Logeart; F Pessione; C Dubois; G Dreyfus; R Gourgon; P Merlet
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

6.  Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.

Authors:  Shu Kasama; Takuji Toyama; Takashi Hatori; Hiroyuki Sumino; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  Eur Heart J       Date:  2007-04-04       Impact factor: 29.983

7.  Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.

Authors:  Tomoaki Nakata; Takeru Wakabayashi; Michifumi Kyuma; Toru Takahashi; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-25       Impact factor: 9.236

8.  Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis.

Authors:  Shinichiro Fujimoto; Aritomo Inoue; Shinji Hisatake; Shohei Yamashina; Hisayo Yamashina; Hajime Nakano; Junichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

9.  Improvement in cardiac adrenergic function post biventricular pacing for heart failure.

Authors:  Paul A Gould; Grace Kong; Victor Kalff; Stephen J Duffy; Andrew J Taylor; Michael J Kelly; David M Kaye
Journal:  Europace       Date:  2007-05-21       Impact factor: 5.214

10.  123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.

Authors:  Arnold F Jacobson; John Lombard; Gopa Banerjee; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

View more
  22 in total

1.  A step forward in the use of SPECT imaging with I-123 MIBG.

Authors:  Mouhamad Abdallah; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

2.  I-123 mIBG and Tc-99m myocardial SPECT imaging to predict inducibility of ventricular arrhythmia on electrophysiology testing: a retrospective analysis.

Authors:  Yanli Zhou; Weihua Zhou; Russell D Folks; Daya N Manatunga; Arnold F Jacobson; Jeroen J Bax; Ernest V Garcia; Ji Chen
Journal:  J Nucl Cardiol       Date:  2014-05-24       Impact factor: 5.952

3.  Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all.

Authors:  Piotr J Slomka; Puja K Mehta; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2014-07-09       Impact factor: 5.952

4.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

5.  Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT.

Authors:  Ian P Clements; Ernest V Garcia; Ji Chen; Russell D Folks; Javed Butler; Arnold F Jacobson
Journal:  J Nucl Cardiol       Date:  2015-03-19       Impact factor: 5.952

6.  Phase dyssynchrony and 123I-meta-iodobenzylguanidine innervation imaging towards standardization.

Authors:  Kenichi Nakajima; Koichi Okuda; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2017-09-18       Impact factor: 5.952

7.  How do we establish cardiac sympathetic nervous system imaging with 123I-mIBG in clinical practice? Perspectives and lessons from Japan and the US.

Authors:  Mark I Travin; Ichiro Matsunari; Gregory S Thomas; Kenichi Nakajima; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2018-09-03       Impact factor: 5.952

8.  Impact of age on myocardial uptake of ¹²³I-mIBG in older adult subjects without coronary heart disease.

Authors:  Arnold F Jacobson; Ji Chen; Liudmilla Verdes; Russell D Folks; Daya N Manatunga; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2013-03-13       Impact factor: 5.952

9.  Relationship between quantitative cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine and hospitalization in patients with heart failure.

Authors:  Matthew W Parker; Nitesh Sood; Alan W Ahlberg; Arnold F Jacobson; Gary V Heller; Justin B Lundbye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-11       Impact factor: 9.236

Review 10.  Cardiac autonomic imaging with SPECT tracers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.